Public psychedelics companies have radically scaled-back capital raising due to low share prices. But institutional investors are still pumping large amounts of cash into private players.

Cybin announces approval to enter its Phase IIa clinical study and defines the scope of the clinical trial.

Over 80% of Americans are exhibiting symptoms of depression related to the COVID-19 pandemic. Nearly 1 in 4 Americans have experienced suicidal or self-destructive thoughts.

A bill to decriminalize psychedelic drugs is currently being considered by the California Legislature.

The Psychedelic Drug Revolution has begun. Standing in the way are politicians and regulators, saddled with archaic anti-drug phobias. They need to be educated.

The FDA has approved the use of MDMA by therapists — to better prepare them to administer MDMA-assisted psychotherapy.

On the day it opened in early May, Field Trip Health’s therapeutic facility in Houston’s uptown neighborhood looked a little like a high-end strip-mall spa. Dressed in a floral shirt, Matt Emmer, the company’s director of operations and business development, showed me the clinic’s amenities.

A new report published in Drug Science, Policy and Law suggests that psychedelic drugs may improve symptoms of color blindness.